Leading-edge cancer care and research have been a hallmark of Duke Medicine for nearly 40 years. Today, the Duke Cancer Institute continues to build on its national and global reputation as one of the foremost centers for cancer diagnosis, treatment, research, education, and training.

“It has never been more critical that a leader step forward to accelerate our understanding of cancer -- and champion the effort to finally defeat it. That leader will be the Duke Cancer Institute.”--Victor J. Dzau, MD, Duke’s chancellor for health affairs

The Duke Cancer Institute provides specialized care to patients, treating every cancer type, with 100 oncology-dedicated, board-certified physicians and 500 clinical staff -- nurses, social workers, nutritionists, and others -- dedicated to cancer.

Since 1993 Duke has ranked among the top centers in the nation for cancer services according to U.S.News & World Report and leader in the southeast.

The Duke Cancer Institute is a single entity -- the first of its kind at Duke -- that brings cancer care and research even closer together. By uniting cancer physicians, researchers, educators, and staff across the medical center, medical school, and health system, the DCI offers unprecedented opportunities for teamwork among the scientists in our labs and caregivers in our hospitals and clinics.

Duke Cancer Institute at a Glance

• DCI serves nearly 6,000 new cancer patients each year -- from every state in the nation and every county in North Carolina
• DCI is a National Cancer Institute-designated comprehensive cancer center -- one of only 41in the nation
• DCI includes more than 300 researchers and physicians and 500 clinical staff
• DCI includes clinical and research partnerships in India, China, Singapore, and across the United States
• The total investment in the Duke Cancer Institute, including a new cancer center facility, is approximately $400 million
• Duke currently receives nearly $300 million annually in cancer research funding from a variety of sources.